Thrombotic Disorders

On this page

Pediatric Clots - Tiny Troubles

  • Definition: Pathological formation of blood clots (thrombi) in arteries or veins in children, obstructing blood flow.
  • Pediatric vs. Adult Differences:
    • Lower incidence in children.
    • Different risk factor profiles (e.g., congenital heart disease, central lines more prominent in peds).
    • Developmental hemostasis: different levels of coagulation factors.
  • Virchow's Triad (Pediatric Context): 📌 SHE
    • Stasis: Immobility, congenital heart disease (CHD) with shunts, Fontan circulation.
    • Hypercoagulability: Sepsis, inherited thrombophilias (e.g., Factor V Leiden, Protein C/S deficiency), nephrotic syndrome, malignancy, certain medications (e.g., L-asparaginase).
    • Endothelial Injury: Central venous lines (CVL), trauma, surgery, vasculitis.

⭐ Central venous lines are a leading risk factor for VTE in hospitalized children.

Virchow's Triad in Pediatric Patient with Central Line

Clot Catalysts - Why Kids Clot

Pediatric thrombosis often results from an interplay between underlying genetic predispositions and various acquired conditions that promote clot formation.

Inherited Thrombophilias: These are genetic defects increasing thrombosis risk.

ConditionMechanism / Note
Factor V LeidenActivated Protein C (APC) resistance
Prothrombin G20210A↑ Prothrombin synthesis
Protein C DeficiencyImpaired inactivation of FVa & FVIIIa
Protein S DeficiencyReduced Protein C cofactor activity
Antithrombin (AT) DeficiencyReduced inhibition of thrombin & FXa

Acquired Risk Factors:

  • Central Venous Lines (CVL): Most common.
  • Sepsis: Systemic inflammation.
  • Malignancy: e.g., ALL; L-asparaginase.
  • Surgery / Trauma.
  • Nephrotic Syndrome: Loses anticoagulants (AT, Protein C/S).
  • Antiphospholipid Syndrome (APS).
  • Kawasaki Disease: Vasculitis, aneurysms.
  • Immobility / Dehydration.

Clot Confirmation - Spotting the Signs

Clinical Presentation (Site-Dependent):

  • DVT: Limb swelling, pain, warmth. Neonates: discoloration, edema.
  • PE: Sudden dyspnea, chest pain, hypoxia.
  • CSVT: Headache, seizures, focal deficits. Neonates: lethargy.
  • Arterial: 5 Ps (Pain, Pallor, Pulselessness, Paresthesia, Paralysis); organ ischemia.
  • Renal Vein (RVT): Flank mass, hematuria, thrombocytopenia (esp. neonates).

Diagnostic Workup:

  • Labs:
    • D-dimer: ↑ (High NPV).
    • Coagulation Profile: PT, aPTT, Fibrinogen.
    • Specific Assays (recurrent/unprovoked): Protein C/S, AT, FVL, Prothrombin G20210A (Timing: ~4-6 weeks post-event, off anticoagulants).
  • Imaging:
    • DVT: Doppler US.

      ⭐ Doppler ultrasound is the initial imaging of choice for suspected DVT.

    • PE: CT Pulmonary Angiography (CTPA); V/Q scan.
    • CSVT: MR Venography (MRV) / CT Venography (CTV).
    • Arterial: Doppler US, CTA/MRA.

Pulmonary Embolism CT Angiography

Clot Combat - Treatment Tactics

  • Core Strategy: Anticoagulation to halt clot growth & prevent recurrence.
    AgentKey FeaturesMonitoring
    LMWHEnoxaparin: 1mg/kg BD (>2mo), 1.5mg/kg BD (<2mo). SC.Anti-Xa levels
    UFHIV infusion. Rapid onset/offset.aPTT
    WarfarinOral. Target INR 2-3. Bridging needed.INR
    DOACsDabigatran, Rivaroxaban. Oral. Fixed doses. Growing pediatric use.Minimal/Specific
  • Thrombolysis (tPA): For severe, life/limb-threatening clots. High bleeding risk.
  • Prophylaxis: Crucial for high-risk (central lines, surgery, inherited thrombophilia).
  • Special Scenarios:
    • Neonatal Thrombosis: Often catheter-related. LMWH is first-line.
    • Purpura Fulminans: Urgent anticoagulation (LMWH/UFH), FFP, Protein C.

⭐ LMWH is generally preferred for anticoagulation in children due to predictable pharmacokinetics and subcutaneous administration.

Pediatric Anticoagulation Therapy Decision Tree

High‑Yield Points - ⚡ Biggest Takeaways

  • Factor V Leiden is the most common inherited thrombophilia; central venous lines are a key acquired risk.
  • Neonatal thrombosis is often linked to umbilical catheters or maternal conditions like Antiphospholipid Syndrome (APS).
  • Severe Protein C or S deficiency can present as neonatal purpura fulminans.
  • Kawasaki disease poses a risk for coronary artery thrombosis from aneurysms.
  • Low Molecular Weight Heparin (LMWH) is the preferred initial anticoagulant in most pediatric thrombotic events.
  • Nephrotic syndrome is a significant acquired risk factor due to urinary loss of anticoagulant proteins.
  • Always investigate for underlying malignancy or sepsis in unexplained pediatric thrombosis.
Rezzy AI Tutor

Have doubts about this lesson?

Ask Rezzy, our AI tutor, to explain anything you didn't understand

Practice Questions: Thrombotic Disorders

Test your understanding with these related questions

A 36-week pregnant woman with mitral stenosis has been on warfarin for anticoagulation. What is the most appropriate next step in her management?

1 of 5

Flashcards: Thrombotic Disorders

1/9

Hb _____ levels are increased in juvenile chronic myeloid leukemia (JMML)

TAP TO REVEAL ANSWER

Hb _____ levels are increased in juvenile chronic myeloid leukemia (JMML)

F

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start For Free
Thrombotic Disorders - Free Indian Medical PG Review